Dexamethasone Sodium Phosphate
- Product NDC
- 70518-2936
- 11-digit product format
- 705182936
- Labeler code
- 70518
- Product ID
- 70518-2936_dd1815f7-a5b7-33c8-e053-2995a90aa8d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dexamethasone Sodium Phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA040803
- Marketing category
- ANDA
- Marketing start
- 2020-11-09
- Marketing end
- 0000-00-00
- Substance
- DEXAMETHASONE SODIUM PHOSPHATE
- Active strength
- 4 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| AI9376Y64P | DEXAMETHASONE SODIUM PHOSPHATE | 2392-39-4 | DEXAMETHASONE SODIUM PHOSPHATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2936-0 | 70518293600 | 25 VIAL in 1 CARTON (70518-2936-0) > 1 mL in 1 VIAL (70518-2936-1) | 25 vial | 2020-11-09 | 0000-00-00 | No | No | Current |